Wedbush Boosts Price Target on NPS Pharmaceuticals (NPSP) After Amended Amgen Deal
Go back to Wedbush Boosts Price Target on NPS Pharmaceuticals (NPSP) After Amended Amgen Deal| NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) | Delayed: 45.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.97 | 52 Week High | $46.01 | |||
| Open | $1.82 | 52 Week Low | $22.11 | |||
| Day High | $45.97 | P/E | N/A | |||
| Day Low | $45.97 | EPS | $-0.14 | |||
| Volume | 6,432 | |||||
